⚠️ DMRA 1954 reminder: Available treatments dementia progression ko slow karte hain. Koi treatment dementia ko reverse, cure, ya memory restore nahi karta. Kisi bhi aisa claim ko reject karein.
Cholinesterase inhibitors (Donepezil, Rivastigmine, Galantamine): Mild-to-moderate Alzheimer's mein use hote hain. Acetylcholine ka level brain mein increase karte hain. Symptoms ko 6-12 months tak stabilize kar sakte hain. Side-effects: nausea, diarrhea, bradycardia (slow heart rate), vivid dreams. Generic India mein affordable hain (₹100-500/month).
Memantine (NMDA antagonist): Moderate-to-severe Alzheimer's mein. Often donepezil ke saath combine karke prescribe hota hai. Glutamate excitotoxicity reduce karta hai. Side-effects relatively mild.
Lecanemab + Donanemab (anti-amyloid antibodies): 2023-2024 mein FDA approved. Modestly slow progression (~27-35% rate reduction over 18 months). India mein extremely limited availability + cost prohibitive (~₹50 lakh+/year). ARIA (amyloid-related imaging abnormalities) — brain swelling/bleeding — serious risk. Yeh BHI cure nahi hai, sirf modest slowing.
Behavior management: Yeh actually backbone hai dementia care ka. Non-drug strategies pehle try karein — routine, environment modification, triggers identification. Antipsychotics (jaise risperidone, quetiapine) sirf severe agitation/psychosis mein, lowest dose, shortest duration — kyunki dementia patients mein mortality risk increase karte hain (FDA black box warning).
Reversible contributors treat karein: B12 deficiency replacement, hypothyroidism levothyroxine, depression antidepressants, OSA CPAP. Pseudo-dementia mein cognition substantial recover hoti hai depression treat karne se.
Vascular dementia specific: Stroke prevention focus — BP < 130/80, diabetes A1c < 7, statin for cholesterol, antiplatelet (aspirin) selectively, smoking cessation absolute. Further infarcts prevent karna = further decline prevent karna.